BE854268A - PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION - Google Patents

PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION

Info

Publication number
BE854268A
BE854268A BE177278A BE177278A BE854268A BE 854268 A BE854268 A BE 854268A BE 177278 A BE177278 A BE 177278A BE 177278 A BE177278 A BE 177278A BE 854268 A BE854268 A BE 854268A
Authority
BE
Belgium
Prior art keywords
pyrrolidons
preparation process
therapeutic application
therapeutic
application
Prior art date
Application number
BE177278A
Other languages
French (fr)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BE854268A publication Critical patent/BE854268A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BE177278A 1976-05-04 1977-05-04 PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION BE854268A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619638 DE2619638A1 (en) 1976-05-04 1976-05-04 PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Publications (1)

Publication Number Publication Date
BE854268A true BE854268A (en) 1977-11-04

Family

ID=5977020

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177278A BE854268A (en) 1976-05-04 1977-05-04 PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION

Country Status (9)

Country Link
JP (1) JPS52133975A (en)
BE (1) BE854268A (en)
DE (1) DE2619638A1 (en)
DK (1) DK194377A (en)
ES (1) ES458264A1 (en)
FR (1) FR2372806A1 (en)
GB (1) GB1583163A (en)
IT (1) IT1086223B (en)
NL (1) NL7704739A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
WO2003074483A1 (en) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321201A (en) 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
EP0440789A1 (en) * 1988-04-22 1991-08-14 2-i MOSKOVSKY GOSUDARSTVENNY MEDITSINSKY INSTITUT IMENI N.I. PIROGOVA Carbalkoxymethyl ethers of lactam-1-acetic acid and method of obtaining them
AU1293101A (en) 1999-12-22 2001-07-03 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
CA2429850C (en) * 2000-11-27 2008-12-30 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
KR20040015364A (en) * 2001-07-16 2004-02-18 에프. 호프만-라 로슈 아게 Prostaglandin analogues as ep4 receptor agonists
BR0211167A (en) 2001-07-16 2004-08-10 Hoffmann La Roche 2-Pyrrolidone derivatives as prostanoid agonists
MXPA04000757A (en) 2001-07-23 2004-07-08 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4.
EP1556347A4 (en) * 2002-06-10 2006-08-09 Applied Research Systems Gamma lactams as prostaglandin agonists and use thereof
CA2511255C (en) 2003-01-10 2009-04-07 F. Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists
WO2004065365A1 (en) * 2003-01-21 2004-08-05 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2006043655A1 (en) 2004-10-22 2006-04-27 Ono Pharmaceutical Co., Ltd. Medicinal composition for inhalation
CA2879506C (en) 2012-07-19 2020-10-27 Cayman Chemical Company, Inc. Difluorolactam compositions for ep4-mediated osteo related diseases and conditions
US9676712B2 (en) 2013-03-15 2017-06-13 Cayman Chemical Company, Inc. Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions
CA2903314C (en) 2013-03-15 2023-02-14 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
EA201591793A1 (en) * 2013-03-15 2016-01-29 Кайман Кемикал Компани, Инк. LACTAM COMPOUNDS AS SELECTIVE AGONISTS OF EP4 RECEPTORS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASES AND STATES
EP3021879A2 (en) 2013-07-19 2016-05-25 Cayman Chemical Company, Incorporated Methods, systems, and compositions for promoting bone growth

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
WO2003074483A1 (en) 2002-03-05 2003-09-12 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient

Also Published As

Publication number Publication date
JPS52133975A (en) 1977-11-09
FR2372806A1 (en) 1978-06-30
DE2619638A1 (en) 1977-11-17
IT1086223B (en) 1985-05-28
ES458264A1 (en) 1978-07-16
DK194377A (en) 1977-11-05
FR2372806B1 (en) 1980-02-29
NL7704739A (en) 1977-11-08
GB1583163A (en) 1981-01-21

Similar Documents

Publication Publication Date Title
LU80081A1 (en) NEW HYDROXYMETHYL-5 OXAZOLIDINONES-2, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE878723A (en) 4-ANILINOQUINAZOLINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2383157B1 (en) CHALCON DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE867421A (en) MEVALONOLACTONE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2393795B1 (en) CARBOSTYRYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
FR2340950A1 (en) CEFUROXIME ESTERS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE854268A (en) PYRROLIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE851893A (en) NEW ARYL-3 OXAZOLIDINONES-2, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE846452A (en) NEW PYRIMIDONS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE847090A (en) 15-STEROIDS, AND THEIR PREPARATION PROCESS
FR2458547B2 (en) NOVEL AZOLONES N-ARYLE, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE864312A (en) NEW PYRROLIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2349587A1 (en) 1,3-DIHYDRO-HETEROARYLSPIRO (ISOBENZOFURANNES), THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE865805A (en) 1,2,3-THIADIAZOL-3-IN-5-YLIDENE-UREES, THEIR PREPARATION PROCESS AND THEIR USE
FR2351965A1 (en) BENZENESULFONYLUREES, THEIR PROCESS FOR PREPARATION AND THEIR THERAPEUTIC APPLICATION
LU79606A1 (en) BISAMIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2353520A1 (en) 1-ARYLOXY-2-HYDROXY-3-AMINOPROPANES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
BE866928A (en) BENZENE-SULFONYL UREES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
LU78873A1 (en) ALKYLTHIO-7,8-DIHYDROXY-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, THEIR PREPARATION PROCESS AND THERAPEUTIC APPLICATION
FR2351098A1 (en) ISOTHIOUREA DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE860773A (en) MONOCYCLIC BETA-LACTAMES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE868659A (en) NEW BENZAMIDINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
BE835828A (en) NEW 1,4-BENZODIOXANES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
BE866648A (en) TRIAZOLOTHIADIAZINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATIONS
FR2340951A1 (en) CEFUROXIME DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION